Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?

por Mao, Zhifeng, Álvarez-Gonzalez, César, De Trane, Stefania, Yildiz, Ozlem, Albor, Christo, Doctor, Gabriel, Soon, Derek, Pepper, George, Turner, Benjamin P, Marta, Monica, Mathews, Joela, Giovannoni, Gavin, Baker, David, Schmierer, Klaus
Publicado 2018

International consensus on quality standards for brain health-focused care in multiple sclerosis

por Hobart, Jeremy, Bowen, Amy, Pepper, George, Crofts, Harriet, Eberhard, Lucy, Berger, Thomas, Boyko, Alexey, Boz, Cavit, Butzkueven, Helmut, Celius, Elisabeth Gulowsen, Drulovic, Jelena, Flores, José, Horáková, Dana, Lebrun-Frénay, Christine, Marrie, Ruth Ann, Overell, James, Piehl, Fredrik, Rasmussen, Peter Vestergaard, Sá, Maria José, Sîrbu, Carmen-Adella, Skromne, Eli, Torkildsen, Øivind, van Pesch, Vincent, Vollmer, Timothy, Zakaria, Magd, Ziemssen, Tjalf, Giovannoni, Gavin
Publicado 2018